sulfiram 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
3569 95-05-6

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • sulfiram
  • sulfirame
  • sulfiramum
  • tetrucid
  • Molecular weight: 264.46
  • Formula: C10H20N2S3
  • CLOGP: 2.54
  • LIPINSKI: 0
  • HAC: 2
  • HDO: 0
  • TPSA: 6.48
  • ALOGS: -4.35
  • ROTB: 6

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 3.733 Moderate 0.72
caco2-efflux Caco-2 efflux ratio (BA/AB) 1.340 Moderate 0.72
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 66.222 10^-6 cm/s Moderate 0.72
dh-clint Dog hepatocyte intrinsic clearance 367.282 uL/min/10^6 cells Moderate 0.72
dppb Dog plasma protein binding (% unbound) 4.150 % Moderate 0.72
fcs-ppb Fetal calf serum protein binding (% unbound) 2.320 % Moderate 0.72
herg hERG pIC50 4.871 pIC50 Moderate 0.72
hh-clint Human hepatocyte intrinsic clearance 34.834 uL/min/10^6 cells Moderate 0.72
hlm-clint Human liver microsomal intrinsic clearance 49.659 uL/min/mg protein Moderate 0.72
hppb Human plasma protein binding (% unbound) 2.400 % Moderate 0.72
kinase-safety-class ACVR2A,ACVR2B,AKT2,AKT3,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GSK3B,ITK,JAK2,JAK3,MAP2K6,MAP3K1,MAP3K21,MAP3K7,MAPK10,MAPK7,MAPK8,MAPK9,MAPKAPK2,MARK4,MELK,MET,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIM2,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TTK,ULK1,ZAP70 57
kinase-selectivity-class AXL,BRAF,CAMK2D,CDK16,CDK4,CDK9,DDR1,DYRK1B,EPHB4,ERBB2,FGFR1,FLT4,GRK2,GSK3A,GSK3B,JAK2,MAP2K4,MAP2K6,MAP3K14,MAP3K2,MAP3K7,MAPK10,MAPK12,MAPK7,MTOR,PRKDC,SIK2,STK33,SYK,TEK,TTK,TYRO3,ZAP70 33
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 0.068 Moderate 0.72
mh-clint Mouse hepatocyte intrinsic clearance 430.527 Moderate 0.72
mppb Mouse plasma protein binding (% unbound) 4.960 Moderate 0.72
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 0.044 Moderate 0.72
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 4.690 % Moderate 0.72
rh-clint Rat hepatocyte intrinsic clearance 259.418 uL/min/10^6 cells Moderate 0.72
rh-fuinc Rat hepatocyte fraction unbound in incubation 49.830 % Moderate 0.72
rppb Rat plasma protein binding (% unbound) 1.690 % Moderate 0.72
solubility-dd Solubility at pH 7.4 in DMSO 13.646 uM Moderate 0.72

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Alcoholism indication 7200002
Cirrhosis of liver contraindication 19943007 DOID:5082
Chronic glomerulonephritis contraindication 20917003
Alcohol intoxication contraindication 25702006
Hypothyroidism contraindication 40930008 DOID:1459
Conduction disorder of the heart contraindication 44808001
Chronic heart failure contraindication 48447003
Nephritis contraindication 52845002 DOID:10952
Coronary arteriosclerosis contraindication 53741008 DOID:3393
Psychotic disorder contraindication 69322001
Diabetes mellitus contraindication 73211009 DOID:9351
Epilepsy contraindication 84757009 DOID:1826
Disease of liver contraindication 235856003 DOID:409
Cognitive Impairment following Traumatic Brain Injury contraindication




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D08545 KEGG_DRUG
C0066779 UMLSCUI
CHEBI:135093 CHEBI
CHEMBL2004297 ChEMBL_ID
7215 PUBCHEM_CID
4006 INN_ID
1XHL4Q8P7Y UNII
30206 RXNORM
004043 NDDF
333092000 SNOMEDCT_US
417533007 SNOMEDCT_US
1XHL4Q8P7Y INXIGHT DRUGS

Pharmaceutical products:

None